"*" indicates required fields Or call us directly: +1 213-325-3373 *Cagrilintide is an investigational medication that has completed Phase 3 clinical trials but is NOT yet FDA approved for commercial sale
They are not for human consumption, medical treatment, diagnosis, or disease prevention
: , ,
Some prescribers will start one peptide first, stabilize, then add the second, specifically to isolate the contribution of each
BPC-157 in Orthopaedic Sports Medicine Systematic Review (PMC, 2024) A systematic review of BPC-157 in orthopaedic sports medicine published in PMC confirmed its pre-clinical evidence across fractures, tendon ruptures, ligament tears, and muscle injuries
They are structurally and functionally distinct research compounds